Industry Supported Sessions

​Thursday June 23, 2016

How does a Multidisciplinary Approach Ensure Optimization of Antiemetic Care in Alignment with Guidelines in day-to-day Practice?
Industry Symposium Supported by MSD
Thursday June, 23 – 11:30-13:00 at Hall M

11:30-11:40Welcome & Introduction – Karin Jordan, Germany
11:40-11:55CINV Pathways  - Christine Carrington, Australia
12:00-12:20How do new clinical findings in MEC patients provide evidence for expanded use of NK1 inhibitors? (Review of MEC 031 trial and SENRI trial)  - Karin Jordan, Germany
12:25-12:45Current Global CINV Guidelines and how to incorporate into clinical practice – Michael Green, Australia
12:45-13:00Q&A & Closing Remarks – Faculty

Friday, June 24, 2016

"Teva Symposium: Solutions in Supportive Care"
Industry Symposium Supported by Teva
Friday, June 24 – 08:00-09:00 at Hall L

​​08:00-08:05Welcome – Ian Olver, Australia
08:05-08:15Patient voice: Preliminary results of a pilot project on patient's perspective on pain – Carey-Ann Jackson, Australia
08:15-08:35Simple solutions to a complex problem: Real-life experience of cancerpain management using fentanyl Rapid Onset Opioids Giovanni Rosti, Italy
08:35-08:55The story of granulocyte-colony stimulating factors – Associate Professor Daniel Kurnik, Israel
08:55-09:00Conclusion Q&A

Friday, June 24, 2016

Overcome existing challenges in opioid induced constipation and oral mucositis with new approaches.
Industry Symposium Supported by Mundipharma
Friday, June 24 – 08:00-09:00 at Hall M


Cancer Pain: Overcome existing

challenges in opioid induced constipation

with new approaches – Sam Ahmedzai, UK

  • The mechanism of opioid induced constipation (OIC)
  • and prevalence
  • Impact of OIC in cancer patients
  • Conventional strategy to prevent OIC
  • The role of opioid agonist/antagonist to minimize OIC

Overcome existing challenges in oral mucositis with new approaches – Jeeve Kanagalingam, Singapore, Singapore

  • Are we over relying on patients as a precursor?
  • How can we partner with patients to meet their needs?
  • The prophylactic role of oral hygiene and
  1. medicated mouthwashes


Friday, June 24, 2016

Shared decision-making in supportive care: a symptom-free journey for patients with cancer.
Industry Symposium Supported by Helsinn
Friday, June 24 – 12:30-14:00 at Hall M

12:30–14:00Chair: Dorothy Keefe, Australia

Unique interactive satellite symposium Cased-based scenarios from toxicity of cancer treatment to the management of nutrition impact symptoms, including

  • Nausea and vomiting
  • Cancer anorexia–cachexia
  • Mucositis
  • Gastrointestinal problems


  • Jervoise Andreyev, UK
  • Snezana Bosnjak, Serbia
  • David Currow, Australia

Friday, June 24, 2016

​Houston, We Still Have a Problem: Patients Continue to Experience Chemotherapy-Induces Nausea and Vomiting
a prIME Oncology symposium supported by Tesaro.
Friday, June 24 – 17:45-19:15 at Hall L

1​7:45-17:55Welcome and „Test Your Knowledge" quiz on management of cancer induced nausea and vomiting (CINV) - Ian Olver, Australia
17:55-18:10CINV​: Do we still have a problem? - Karin Jordan, Germany
18:15-18:30The problem with guidelines is that my patient doesn't fit them! - Alex Molassiotis, Hongkong

New solutions to difficult problems - Lee Schwartzberg, USA


Problem solving in routine clinical practice - Ian Olver, Australia

19:10-19:15prIME PointsTM -  Ian Olver, Australia

Keep Me Updated